跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Allerphil
Approved
STANDARD
Allerphil
Mercury Laboratories Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e9883f18a6b21c15
Company
Mercury Laboratories Ltd.
Type
Standard
Approval Details
Approval Id
e9883f18a6b21c15
Drug Approval Philippines Name
Allerphil
Product Name
Allerphil
Registration Number
DRP-12917
Brand Name
Allerphil
Generic Name
Cetirizine Hydrochloride
Dosage Form
Film-Coated Tablet
Dosage Strength
10 mg
Manufacturer
Mercury Laboratories Ltd.
Importer
Philgen Pharmaceuticals Inc.
Distributor
Philgen Pharmaceuticals Inc.
Issuance Date
28 October 2022
Expiry Date
28 October 2027
Pharmacologic Category
Antihistamine (Piperazine derivative)
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e9883f18a6b21c15
Type
Standard
Back to Philippines FDA Approvals
Allerphil - Philippines FDA Drug Approval Details